Posted by Michael Wonder on 16 May 2019
CMS takes action to lower prescription drug prices and increase transparency
16 May 2019 - Final rule modernises the Medicare Advantage & Medicare Part D programs.
Today, the Trump Administration finalised improvements to Medicare Advantage and Medicare Part D, which provide seniors with medical and prescription drug coverage through competing private insurance plans. These changes will ensure that patients have greater transparency into the cost of prescription drugs, so patients can compare options and demand value from pharmaceutical companies.
“The improvements we are making to Medicare Advantage and Medicare Part D deliver on the promises in the President’s blueprint to provide more negotiating tools and more transparency for patients,” said HHS Secretary Alex Azar. “They are significant steps toward a Medicare program, a drug pricing marketplace, and a healthcare system where the patient is at the center and in control.”
